Literature DB >> 8858761

Inflammatory cytokines, nitric oxide, and necrotizing enterocolitis.

H R Ford1, D L Sorrells, A S Knisely.   

Abstract

Numerous theories have been proposed to explain the pathogenesis of necrotizing enterocolitis (NEC). Current evidence suggests that injury to the intestinal barrier as a result of various perinatal insults may facilitate invasion of the intestinal wall by bacteria. An inflammatory cascade ensues, characterized by local release of various cytokines that may contribute to further tissue destruction and hemodynamic instability in NEC. Molecular biological probes show increased expression of inducible nitric oxide synthase and interferon-gamma in the intestine of infants with NEC. Studies are planned to define the role of these inflammatory mediators in a rat model of NEC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858761

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  10 in total

Review 1.  The role of polyunsaturated fatty acid supplementation in intestinal inflammation and neonatal necrotizing enterocolitis.

Authors:  M S Caplan; T Jilling
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

2.  Molecular mechanisms contributing to necrotizing enterocolitis.

Authors:  D H Chung; R T Ethridge; S Kim; S Owens-Stovall; A Hernandez; D R Kelly; B M Evers
Journal:  Ann Surg       Date:  2001-06       Impact factor: 12.969

Review 3.  Cytokines and growth factors in the developing intestine and during necrotizing enterocolitis.

Authors:  Krishnan MohanKumar; Kopperuncholan Namachivayam; Thao T B Ho; Benjamin A Torres; Robin K Ohls; Akhil Maheshwari
Journal:  Semin Perinatol       Date:  2016-11-07       Impact factor: 3.300

4.  Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis.

Authors:  Catherine J Hunter; Monica Williams; Mikael Petrosyan; Yigit Guner; Rahul Mittal; Dennis Mock; Jeffrey S Upperman; Henri R Ford; Nemani V Prasadarao
Journal:  Infect Immun       Date:  2008-12-15       Impact factor: 3.441

5.  M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis.

Authors:  Jia Wei; Gail E Besner
Journal:  J Surg Res       Date:  2015-03-18       Impact factor: 2.192

Review 6.  High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.

Authors:  Valeria Chirico; Antonio Lacquaniti; Vincenzo Salpietro; Caterina Munafò; Maria Pia Calabrò; Michele Buemi; Teresa Arrigo; Carmelo Salpietro
Journal:  Eur J Pediatr       Date:  2014-05-09       Impact factor: 3.183

Review 7.  Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection.

Authors:  Kathryn Burge; Aarthi Gunasekaran; Jeffrey Eckert; Hala Chaaban
Journal:  Int J Mol Sci       Date:  2019-04-18       Impact factor: 5.923

8.  Comprehensive evaluation of 11 cytokines in premature infants with surgical necrotizing enterocolitis.

Authors:  Thomas Benkoe; Suzann Baumann; Manfred Weninger; Mario Pones; Carlos Reck; Winfried Rebhandl; Rudolf Oehler
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

9.  Bacterial colonization stimulates a complex physiological response in the immature human intestinal epithelium.

Authors:  Vincent B Young; Jason R Spence; David R Hill; Sha Huang; Melinda S Nagy; Veda K Yadagiri; Courtney Fields; Dishari Mukherjee; Brooke Bons; Priya H Dedhia; Alana M Chin; Yu-Hwai Tsai; Shrikar Thodla; Thomas M Schmidt; Seth Walk
Journal:  Elife       Date:  2017-11-07       Impact factor: 8.713

10.  Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infants.

Authors:  Akhil Maheshwari; Robert L Schelonka; Reed A Dimmitt; Waldemar A Carlo; Breda Munoz-Hernandez; Abhik Das; Scott A McDonald; Poul Thorsen; Kristin Skogstrand; David M Hougaard; Rosemary D Higgins
Journal:  Pediatr Res       Date:  2014-04-14       Impact factor: 3.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.